DEA Announces New Marijuana Registration Forms For Manufacturing, Distribution And Testing Businesses

Key Points:

• The DEA plans to release new registration forms for various state-licensed medical marijuana businesses, including manufacturers, bulk growers, labs, and distributors, following the recent rescheduling of medical cannabis from Schedule I to Schedule III under the Controlled Substances Act.
• The initial registration form launched last month only covered medical marijuana dispensaries, but the agency will soon expand forms to cover other parts of the cannabis supply chain, with a 60-day expedited registration window closing on June 26.
• The rescheduling order signed by Acting Attorney General Blanche allows state-licensed medical marijuana products and FDA-approved cannabis products to be treated as Schedule III substances, enabling federal protections and regulatory compliance for these businesses.
• The DEA registration process requires detailed disclosures about business operations, security measures, criminal histories, and suppliers, with a non-refundable $794 application fee; meanwhile, the federal government will act as an exclusive purchaser of cannabis crops under the new system.
• The rescheduling is expected to bring tax benefits by allowing marijuana businesses to claim federal deductions previously barred under IRS code 280E, and other agencies like the ATF are updating regulations to reflect the new legal status; the Trump administration supports the move, citing widespread public support and medical benefits.